← All companies

OGI

Organigram Global Inc.

OGI Nasdaq Pharmaceutical Preparations EDGAR ↗

$0.96

-0.00 -0.37%

Key statistics

from XBRL data in SEC filings

Market cap

$105M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$0.85 – $2.24

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 20, 2026 6-K May 12, 2026 6-K May 6, 2026 6-K Apr 16, 2026 6-K Mar 31, 2026 6-K Mar 23, 2026 6-K Mar 11, 2026 6-K FORM 6-K Mar 9, 2026 6-K Mar 5, 2026 6-K Mar 3, 2026 6-K Feb 24, 2026 6-K Feb 20, 2026 6-K Feb 20, 2026 6-K Feb 19, 2026 6-K Feb 18, 2026 6-K Feb 10, 2026 6-K Feb 3, 2026 6-K Jan 28, 2026 6-K Dec 31, 2025 40-F Dec 16, 2025 6-K Dec 5, 2025 6-K Dec 4, 2025 6-K Nov 25, 2025 6-K Oct 29, 2025 6-K Oct 21, 2025 6-K Oct 9, 2025 6-K Sep 2, 2025 6-K Aug 13, 2025 6-K Aug 1, 2025 6-K Jul 8, 2025 6-K Jun 4, 2025 6-K May 27, 2025 6-K May 12, 2025 6-K May 7, 2025 6-K May 5, 2025 6-K May 5, 2025 6-K Apr 29, 2025 6-K Apr 25, 2025 6-K Apr 22, 2025 6-K Apr 16, 2025